摘要
目的 :探讨人文关怀对精神分裂症患者的护理价值。方法 :收集2016年1月至2017年1月收治的精神分裂症患者60例,按照随机数字表法均分为观察组和对照组各30例,对照组接受常规护理,观察组在此基础上实施人文关怀干预。比较两组干预前及干预3个月后阳性和阴性综合征量表(PANSS)、住院精神病患者康复疗效评定量表(IPROS)评分情况、药物治疗依从性、随访12个月的复发和再住院情况。结果 :干预后,观察组PANSS、IPROS评分均显著低于对照组(P <0.05)。观察组药物治疗依从优良率为93.33%(28/30),对照组为73.33%(22/30),组间差异有统计学意义(P <0.05)。观察组随访12个月时的复发率和再住院率分别为23.33%(7/30)和10.00%(3/30),对照组分别为50.00%(15/30)和33.33%(10/30),组间差异均有统计学意义(P <0.05)。结论 :人文关怀能促进精神分裂症患者症状恢复,提升其治疗依从性,降低复发和再住院率,值得临床推荐。
Objective: To explore the nursing value of humanistic care for patients with schizophrenia. Methods: Sixtyschizophrenic patients from January 2016 to January 2017 were collected and randomly divided into an observation group anda control group with 30 cases in each group. The control group received routine care, and the observation group implementedhumanistic care intervention on this basis. The scores of positive and negative syndrome scale(PANSS), in-patient psychiatricrehabilitation observing scale(IPROS) and drug treatment compliance before and after intervention for 3 months, and recurrenceand rehospitalization followed up for 12 months were compared between the two groups. Results: After intervention, the PANSSand IPROS scores in the observation group were significantly lower than those in the control group(P〈0.05). The excellent andgood rate of drug treatment compliance in the observation group was 93.33%(28/30), that in the control group was 73.33%(22/30),and the difference between the two groups was statistically significant(P〈0.05). The recurrence rate and rehospitalization rate inthe observation group in 12 months follow-up were 23.33%(7/30) and 10.00%(3/30), respectively, those in the control group were50.00%(15/30) and 33.33%(10/30), respectively, and the differences between the groups were statistically significant(P〈0.05).Conclusion: Humanistic care can promote the recovery of symptoms in patients with schizophrenia, improve the treatmentcompliance, and reduce the recurrence and rehospitalization rate, which is worthy of clinical recommendation.
作者
刘卫红
胡丽霞
LIU Weihong;HU Lixia(Psychiatry Department of Corelle Hospital of Zhangshu,Jiangxi 331211,China)
出处
《上海医药》
CAS
2018年第22期35-37,共3页
Shanghai Medical & Pharmaceutical Journal